Evidence map›Paper›PMID 18498346›Full record

ArticleImmunology2008

The influence of CD4 T-cell subsets on control of CD4 T-cell-mediated graft-versus-host disease.

Halima Moncrieffe, Mark Coles, Brigitta Stockinger

Open access · bronzeAbstract read
In one paragraph

Article in Immunology, 2008. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed
0.5field-weighted citation impact, top 35% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 12 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Halima MoncrieffeDivision of Molecular Immunology, The MRC National Institute for Medical Research, Mill Hill, London, UK. h.moncrieffe@ich.ucl.ac.uk
Mark Coles
Brigitta Stockinger
MRC Laboratory for Molecular Cell Biology · GB

Funding

Medical Research Council G0601156
6 · The paper itself

Abstract

In this study, we tested the effect of different T-cell subpopulations on antigen driven effector cell expansion in lymphopenic hosts, making use of an experimental model of graft-versus-host disease (GVHD). Fluorescence-activated cell sorted (FACS) naïve CD4 T cells from C57BL/6 mice, transferred into lymphopenic F1 (C57BL/6 x BALB/c) Rag-deficient hosts, proliferated extensively and migrated systemically causing acute GVHD within 4 weeks after transfer. Adoptive hosts of CD4 memory T cells on the other hand developed milder symptoms of GVHD with later onset. T-cell expansion and migration to peripheral sites as well as development of GVHD were prevented when naïve T cells were transferred together with CD4(+) CD25(+) T cells, but co-transfer of memory T cells with naïve T cells could not prevent GVHD, although its onset was delayed. OX40, a costimulatory marker that is upregulated at an early time point after T-cell activation and enhances T-cell proliferation, cytokine secretion and survival, was strongly upregulated during GVH responses. Naïve T cells deficient in OX40 expression caused markedly reduced GVH in onset and severity despite some level of expansion in the adoptive host, suggesting an important role of this molecule in the immune pathology of GVHD.

Indexed as

Adoptive TransferAnimalsCD4-Positive T-LymphocytesDNA-Binding ProteinsFlow CytometryGraft vs Host DiseaseHyaluronan ReceptorsImmunologic MemoryInterleukin-2 Receptor alpha SubunitMiceMice, Inbred BALB CMice, Inbred C57BLMice, KnockoutMice, TransgenicModels, AnimalReceptors, OX40DNA-Binding ProteinsHyaluronan ReceptorsInterleukin-2 Receptor alpha SubunitRag2 protein, mouseReceptors, OX40Tnfrsf4 protein, mouse

Identifiers

PMID18498346
PMCPMC2612549
OpenAlexW2040131032

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.